ACT Price Prediction Next Week
Analysis and Insights
To predict the stock price of ACT.O for the next trading week, we will analyze both technical indicators and recent news sentiment.
Technical Analysis:
The current price of ACT.O is $33.95 as of 2025-03-10. Key technical indicators include:
- RSI (14): 55.72, indicating a neutral position.
- MACD: 0.18, showing a slight bullish signal.
- Stochastic Oscillator: %K (58.19) and %D (59.86), suggesting the stock is in an upper range but not overbought.
- Bollinger Bands: The price is near the lower band, indicating potential volatility or a bounce.
News Sentiment:
Recent news includes:
- The AP suing Trump aides over access restrictions, which may have broader political implications but does not directly impact ACT.O.
- Musk's critique of immigration policies, which is more political and not directly relevant to ACT.O.
- Trump's reversal on Ukraine, which could impact broader market sentiment but lacks direct ties to ACT.O.
Fibonacci Levels:
- Pivot Point: 33.81
- Resistance Levels: 34.58 (R1), 35.05 (R2)
- Support Levels: 33.05 (S1), 32.57 (S2)
Prediction and Recommendation:
Based on the analysis, the stock is expected to trade between $33.05 and $34.58 next week. The slight bullish MACD signal and proximity to the lower Bollinger Band suggest a potential bounce, but without strong news, the movement is likely sideways.
Predicted Price: $34.20
Recommendation: Sell if the stock reaches the resistance level of $34.58, as the upside appears limited.
ACT Similar Chart Price Prediction
The price of ACT is predicted to go up -13.58%, based on the high correlation periods with HZO. The similarity of these two price pattern on the periods is 90.2%.
ACT
HZO
Down: -13.58%Similarity: 90.2%
ACT Revenue Forecast
ACT EPS Forecast
ACT FAQs
What is ACT revenue forecast for next quarter？
What is ACT eps forecast for next quarter？
ACT Analyst's Forecast
Richard Shane
JP Morgan
Hold
2024-12-09
Price Target
$39 → $36
Upside
+5.96%
JPMorgan lowered the firm's price target on Enact Holdings to $36 from $39 and keeps a Neutral rating on the shares. The firm says market outcomes for consumer and specialty finance in 2025 will likely be determined by how far the Trump administration can go in implementing its policy objectives. The stocks already appear to be incorporating many of the more likely outcomes into valuations, with the sector factoring significant regulatory relief, less restrictive capital requirements, and higher capital returns, the analyst tells investors in a research note. JPMorgan believes this limits upside with risk/rewards "skewing unfavorably as premium valuations may constrain returns and downside scenarios could be exacerbated should events fail to unfold as expected."
Richard Shane
JP Morgan
Hold
2024-10-07
Price Target
$36 → $38
Upside
+6.32%
